Mary-Anne Woodnorth

Title: Mary-Anne Woodnorth: Innovator in Cognitive Enhancement

Introduction

Mary-Anne Woodnorth is a notable inventor based in Auckland, New Zealand. She has made significant contributions to the field of cognitive enhancement and therapy. Her work focuses on developing methods to treat cognitive and memory disorders, particularly those associated with aging and neurodegenerative conditions.

Latest Patents

Mary-Anne holds a patent for her invention titled "Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid." This invention provides compounds, compositions, and methods for treating cognitive disorders in animals. The compounds can stimulate neural cell growth and increase the production of a key enzyme necessary for the cholinergic neurotransmitter. This innovation aims to improve memory and cognitive function in animals that have experienced cognitive decline.

Career Highlights

Mary-Anne is associated with Neuren Pharmaceuticals Limited, where she applies her expertise in cognitive therapies. Her work has the potential to impact the treatment of cognitive disorders significantly.

Collaborations

She has collaborated with notable colleagues, including Peter David Gluckman and Jian Guan, to advance her research and innovations in cognitive enhancement.

Conclusion

Mary-Anne Woodnorth's contributions to cognitive therapy and enhancement represent a significant advancement in the treatment of memory disorders. Her innovative approach and dedication to research continue to pave the way for future developments in this critical field.